New to Bioss? Enjoy 35% of your first order. Use code "FirstOrder35" - Offer valid for new U.S. Customers on direct orders only

Contact us at 1.800.501.7654 or info@biossusa.com

MenuSearch

Recombinant SARS-COV-2 Spike S1 (D614G) Protein

Recombinant SARS-CoV-2 Spike S1 (D614G) Protein on Tris-Bis PAGE under reduced condition. The purity is greater than 95%.
Recombinant SARS-CoV-2 Spike S1 (D614G) Protein on Tris-Bis PAGE under reduced condition. The purity is greater than 95%.
The purity of Recombinant SARS-CoV-2 Spike S1 (D614G) Protein is greater than 95% as determined by SEC-HPLC.
The purity of Recombinant SARS-CoV-2 Spike S1 (D614G) Protein is greater than 95% as determined by SEC-HPLC.
Immobilized SARS-CoV-2 Spike S1 (D614G) at 2ug\/ml (100ul\/Well). Dose-response curve for Human ACE2, Fc tag with the EC50 of 42ng\/ml determined by ELISA.
Immobilized SARS-CoV-2 Spike S1 (D614G) at 2ug\/ml (100ul\/Well). Dose-response curve for Human ACE2, Fc tag with the EC50 of 42ng\/ml determined by ELISA.

Applications

  • WB
  • ELISA
  • HPLC

Reactivity

  • SARS-CoV-2
Overview
Catalog # bs-46010P
Product Name Recombinant SARS-COV-2 Spike S1 (D614G) Protein
Applications WB, ELISA, HPLC
Reactivity SARS-CoV-2
Specifications
Conjugation Unconjugated
Source SARS-COV-2 Spike S1 (D614G) Protein is expressed with a His-tag and Avi at the C-terminal.
Storage Buffer Lyophilized from 0.22um filtered solution in 20mM PB (pH 7.4). 5% trehalose is added as a protectant before lyophilization.
Storage Condition The product should be stored at -70°C or -20°C.
Target
Swiss Prot QHD43416.1
Background The SARS-CoV-2 spike (S) protein is the target of vaccine design efforts to end the COVID-19 pandemic. Despite a low mutation rate, isolates with the D614G substitution in the S protein appeared early during the pandemic, and are now the dominant form worldwide. Here, we analyze the D614G mutation in the context of a soluble S ectodomain construct.

Search our catalog of hundreds of thousands of products